Nurse practitioner interventions for smokers with chronic hepatitis C.
Journal
Journal of the American Association of Nurse Practitioners
ISSN: 2327-6924
Titre abrégé: J Am Assoc Nurse Pract
Pays: United States
ID NLM: 101600770
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
9
11
2019
medline:
11
2
2021
entrez:
9
11
2019
Statut:
ppublish
Résumé
Smoking is a grossly overlooked risk factor for people with chronic hepatitis C with regard to disease progression. It is unclear whether current smoking cessation interventions are effective for this population. The purpose was to evaluate the effectiveness of a telephone counseling and nicotine replacement therapy (NRT) intervention for smokers with chronic hepatitis C to quit or reduce rates of smoking. A randomized controlled trial was conducted with participants randomized and stratified according to heaviness of smoking. Ninety-two eligible adults who smoked cigarettes and attended hepatology outpatient clinics were recruited. The intervention included NRT and telephone counseling compared with telephone counseling alone. Data collection occurred from December 2010 to November 2011. Data were collected at baseline, 6, and 12 weeks to assess smoking cessation. Change scores were analyzed using analysis of variance to examine the differences between smoking interventions. At 6 weeks, both control and intervention groups had quit or reduced the number of cigarettes smoked daily. However, over 12 weeks, the intervention group showed sustained quitting or reduced smoking, with 5.8 (confidence interval [CI]: 2.4, 9.3) fewer cigarettes smoked per day from baseline. The control group maintained an average reduction of 1.6 (CI: -1.9, 5.2) fewer cigarettes per day. Nicotine replacement therapy and individualized telephone counseling interventions increase the prospects of smoking cessation. Interventions such as these, introduced at routine clinic appointments in the outpatients' setting, by a nurse practitioner (hepatology) showed clinically important results for smoking cessation in this population.
Sections du résumé
BACKGROUND
BACKGROUND
Smoking is a grossly overlooked risk factor for people with chronic hepatitis C with regard to disease progression. It is unclear whether current smoking cessation interventions are effective for this population.
PURPOSE
OBJECTIVE
The purpose was to evaluate the effectiveness of a telephone counseling and nicotine replacement therapy (NRT) intervention for smokers with chronic hepatitis C to quit or reduce rates of smoking.
METHODS
METHODS
A randomized controlled trial was conducted with participants randomized and stratified according to heaviness of smoking. Ninety-two eligible adults who smoked cigarettes and attended hepatology outpatient clinics were recruited. The intervention included NRT and telephone counseling compared with telephone counseling alone. Data collection occurred from December 2010 to November 2011. Data were collected at baseline, 6, and 12 weeks to assess smoking cessation. Change scores were analyzed using analysis of variance to examine the differences between smoking interventions.
RESULTS
RESULTS
At 6 weeks, both control and intervention groups had quit or reduced the number of cigarettes smoked daily. However, over 12 weeks, the intervention group showed sustained quitting or reduced smoking, with 5.8 (confidence interval [CI]: 2.4, 9.3) fewer cigarettes smoked per day from baseline. The control group maintained an average reduction of 1.6 (CI: -1.9, 5.2) fewer cigarettes per day.
IMPLICATIONS FOR PRACTICE
CONCLUSIONS
Nicotine replacement therapy and individualized telephone counseling interventions increase the prospects of smoking cessation. Interventions such as these, introduced at routine clinic appointments in the outpatients' setting, by a nurse practitioner (hepatology) showed clinically important results for smoking cessation in this population.
Identifiants
pubmed: 31702602
doi: 10.1097/JXX.0000000000000311
pii: 01741002-202005000-00008
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Pagination
380-389Références
Australian Institute of Health and Welfare. (2016). Australia's health 2016—Australia's health series (No. 15, Cat. No. AUS 199). Canberra, Australia: Australian Institute of Health and Welfare.
Berlin I., Covey L. S. (2006). Pre-cessation depressive mood predicts failure to quit smoking: The role of coping and personality traits. Addiction, 101, 1814–1821.
Chuang S.-C., Lee Y.-C., Hashibe M., Dai M., Zheng T., Boffetta P. (2010). Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: A meta-analysis. Cancer Epidemiology Biomarkers and Prevention, 19, 1261.
Dev A., Patel K., Conrad A., Blatt L. M., McHutchison J. G. (2006). Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clinical Gastroenterology and Hepatology, 4, 797–801.
El-Zayadi A. R. (2006). Heavy smoking and liver. World Journal of Gastroenterology, 12, 6098.
El-Zayadi A. R., Selim O., Hamdy H., El-Tawil A., Badran H. M., Attia M., Saeed A. (2004). Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients. World Journal of Gastroenterology, 10, 2963–2966.
Gritz E. R., Vidrine D. J., Fingeret M. C. (2007). Smoking cessation: A critical component of medical management in chronic disease populations. American Journal of Preventive Medicine, 33, S414–S422.
Hartmann-Boyce J., Chepkin SC., Ye W., Bullen C., Lancaster T. (2018). Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews, 5, CD000146.
Heatherton T., Kozlowski L., Frecker R., Fagerstrom K. (1991). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction, 86, 1119–1127.
Hézode C., Lonjon I., Roudot-Thoraval F., Mavier J.-P., Pawlotsky J.-M., Zafrani E. S., Dhumeaux D. (2003). Impact of smoking on histological liver lesions in chronic hepatitis C. Gut, 52, 126–129.
Kirby Institute. (2016). HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report. Sydney, Australia: Kirby Institute, UNSW.
Levensky E. R., Forcehimes A. M., O'Donohue W. T., Beitz K. (2007). Motivational interviewing: An evidence based approach to counselling helps patients follow treatment recommendations, American Journal of Nursing, 107, 50–58.
Lindson-Hawley N., Thompson T. P., Begh R. (2015) Motivational interviewing for smoking cessation. Cochrane Database of Systematic Reviews, 3, CD006936.
Lovibond S. H., Lovibond P. F. (1995). Manual for the depression anxiety & stress scales (2nd ed.). Sydney, Australia: Psychology Foundation.
McClave A., Dube S., Strine T., Mokdad A. (2009). Associations between health-related quality of life and smoking status among a large sample of US adults. Preventive Medicine, 48, 173–179.
Miller W., Rose G. (2009). Toward a theory of motivational interviewing. American Psychologist, 64, 527–537.
Murphy B., Herman H., Hawthorne G., Pinzone T., Evert H. (2000). Australian WHOQOL instruments: User's manual and interpretation guide. Melbourne, Australia: Australian WHOQOL Field Study Centre.
National Institute on Drug Abuse NIDA. (2018). Viral Hepatitis—A very real consequence of substance use. Retrieved from https://www.drugabuse.gov/related-topics/viral-hepatitis-very-real-consequence-substance-use. Accessed September 14, 2018.
Pessione F., Ramond M. J., Njapoum C., Duchatelle V., Degott C., Erlinger S., Rueff B., Valla DC., Degos F. (2001). Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology, 34, 121–125.
Pessione F., Ramond M. J., Peters L., Pham B. N., Batel P., Rueff B., Valla D. C. (2003). Five-year survival predictive factors in patients with excessive alcohol in-take and cirrhosis: Effect of alcoholic hepatitis, smoking and abstinence. Liver International, 23, 45–53.
Porter L. K. (2018) Hepatitis C and substance use research from the 2018 International Liver Congress. Retrieved from https://www.hepmag.com/blog/hepatitis-c-substance-use-research-2018-international-liver-congress. Accessed September 14, 2018.
Queensland Government. (2016). Queensland health smoking management policy: Implementation guide. Retrieved from http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.395.7327&rep=rep1&type=pdf.
Queensland Government. (2018). QUiT HQ. Retrieved from https://quithq.initiatives.qld.gov.au/quit-support/quitline/get-help-from-quitline/.
Rice V. H., Heath L., Livingstone-Banks J., Hartmann-Boyce J. (2017) Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews, 12, CD001188.
Rosengren A., Wilhelmsen L., Wedel H. (1992). Coronary heart disease, cancer and mortality in male middle-aged light smokers. Journal of Internal Medicine, 231, 357–362.
Schmitz N., Kruse J., Kugler J. (2003). Disabilities, quality of life, and mental disorders associated with smoking and nicotine dependence. American Journal of Psychiatry, 160, 1670–1676.
Scollo M. M., Winstanley M. H. (2018). Tobacco in Australia: Facts and issues. Melbourne, Australia: Cancer Council Victoria. Retrieved from www.TobaccoInAustralia.org.au. Accessed September 14, 2018.
Skevington S., Lotfy M., O'Connell K. (2004). The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial—a report from the WHOQOL Group. Quality of Life Research, 13, 299–310.
Stead L. F., Hartman- Boyce J., Perera R., Lancaster T. (2013). Telephone counselling for smoking cessation. The Cochrane Database of Systematic Reviews, 8. doi: 10.1002/14651858.CD002850.pub3.
doi: 10.1002/14651858.CD002850.pub3
Studts J. L., Ghate S. R., Gill J. L., Studts C. R., Barnes C. N., LaJoie A. S., LaRocca R. V. (2006). Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiology and Prevention Biomarkers, 15, 1825–1828.
Thurgood S. L., McNeill A., Clark-Carter D., Brose L. S. (2016). A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery, Nicotine and Tobacco Research, 18, 993–1001.
WHO. (2016). New recommendations in the updated WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection—Policy brief. Retrieved from http://apps.who.int/iris/bitstream/10665/204452/1/WHO_HIV_2016.01_eng.pdf?ua=1.
World Health Organisation. (2019). Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection (updated version, 2016). Retrieved from https://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2016/en/.
Zhou C., Wu L., Q., An H., Jiang B., Zuo F., He Y. (2017). Evaluation of smoking cessation intervention in patients with chronic diseases in smoking cessation clinics. Medicine, 96, e7459.